Extragonadal steroids influence androgen receptor activity, castration resistance in prostate cancer
Extragonadal steroids have significant contributions to the activation of the androgen receptor axis pathway at castration levels of testosterone in patients with recurrent nonmetastatic prostate cancer, suggests a study. In addition, these steroids promote the development of castration resistance following primary local treatment.
Extragonadal steroids influence androgen receptor activity, castration resistance in prostate cancer
08 May 2020